Two doses of Covid vaccines provide effective protection against variant found in India: Study
A new study has found that two doses of either the Pfizer-BioNTech or AstraZeneca-University of Oxford vaccine give effective protection against the Covid variant first discovered in India, however it underscored the need for two doses, as both vaccines were significantly less effective after only one shot.
The study, led by Public Health England also found that two doses of the vaccine were similarly as effective at protecting against the variant that first emerged in the U.K. and has since become a dominant strain in the West.
Dr Jenny Harries, CEO of the U.K. Health Security Agency, told the BBC that the study provided the "first real-world evidence of vaccine effectiveness" against the variant first identified in India.
Conducted between April and May, the research found that the Pfizer-BioNTech vaccine was 88% effective against symptomatic disease from the B.1.617.2 Covid variant — a sub-type of a variant that emerged in India last fall which has since spread to Europe — two weeks after the second dose. The vaccine was 93% effective two weeks after the second dose against the B.1.1.7 variant which was first discovered in the U.K. last fall.
https://www.msn.com/en-us/health/medical/two-doses-of-covid-vaccines-provide-effective-protection-against-variant-found-in-india-study/ar-AAKk3SN
= new reply since forum marked as read
